Whitepapers 19 Jan 2026Robust lentiviral manufacturing platforms in the age of accessible cell therapy Discover how lentiviral platforms and ready-to-deploy CAR-T solutions are overcoming barriers of global access to life-saving cures. January 19, 2026 Share WhatsApp Twitter Linkedin Email
More News! 16 Jan 2026 JPM 2026: what’s the outlook like this year? This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to attendees at JPM. January 16, 2026 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 16 Jan 2026Labiotech’s 15 biopharma companies to watch in 2026 January 16, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 14 Jan 2026 The AbbVie strategy, a company at an inflection point Look into AbbVie’s strategy a company built around its blockbuster Humira, now diversifying its pipeline after the patent cliff. January 14, 2026 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Jan 2026 Seven biotech companies to know in the Netherlands Explore some of the top biotech companies in the Netherlands, which has established itself as a burgeoning biotech and life sciences hub. January 13, 2026 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Jan 2026 14 biotech podcasts to tune into in 2026 Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry. January 12, 2026 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 Jan 2026 The biggest biotech funding rounds in December 2025 The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in December 2025. January 9, 2026 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 9 Jan 2026M Ventures: pharma CVC and biotech innovation in 2026 Today, we’re joined by Hakan Goker, Managing Director at M Ventures, the strategic corporate venture capital arm of Merck KGaA. January 9, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 8 Jan 2026 Can the thymus be drugged? TECregen raises $12 million to find out Find out about TECregen’s, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics.” January 8, 2026 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 Jan 2026 Top biotech deals in December 2025 As we head into the 2026, let’s take a look at biotech licensing deals and M&As that were inked in December 2025. January 7, 2026 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Dec 2025 When biotech makes Christmas miracles happen — second edition As 2025 comes to a close, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling like a miracle. December 26, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Dec 2025 The best biotech movies to watch this winter Dive into the world of biotech cinema this holiday season! Our list of biotech movies offers the perfect blend of science and entertainment. December 22, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email